Regeneron
- Amanda Bridges
- March 25, 2021
- No Comments
LIBTAYO Surround Product Website CSCC Study Results CSCC Patient Examples Patient Resources
Elite
Jazz Pharmaceuticals plc
- Amanda Bridges
- October 6, 2020
- No Comments
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from…
Gilead
- Amanda Bridges
- September 25, 2020
- No Comments
Gilead, is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping people with hard-to-treat cancers. The impossible is simply what hasn’t been achieved yet. Gilead’s research and development program is focused on what’s next. Their goal is to discover, identify and evaluate investigational compounds that show potential to advance the treatment of…
Daiichi Sankyo, Inc.
- Amanda Bridges
- March 19, 2020
- No Comments
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies…
BeOne Medicines US
- Katrina Williams
- November 13, 2019
- No Comments
Website: https://beonemedicines.us/ Patient Support: https://www.mybeonesupport.com/
Stemline Therapeutics
- Katrina Williams
- February 6, 2019
- No Comments
Company Overview Stemline Therapeutics, Inc. (“Stemline”) a wholly-owned subsidiary of the Menarini Group, is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. Our dedicated team of scientists, specialists, researchers, and developers are committed to providing transformational oncology treatments to those who need it, with the ultimate goal of improving…
Incyte Corporation
- Amanda Bridges
- July 16, 2015
- No Comments
OVERVIEW Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines. Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value…
Sanofi
- April 24, 2015
- No Comments
Overview Sanofi’s focus on patients has driven our historical and ongoing strategy to create long-term value by researching and delivering innovative treatments. Sanofi Oncology’s heritage in oncology has given us an extensive knowledgebase that enriches our current research expertise. This experience encompasses a wide variety of cancer types, disease stages, patient populations, and patient needs….
GSK Oncology
- April 23, 2015
- No Comments
GSK Oncology’s mission and purpose is to deliver potentially transformative medicines and industry-leading programs that provide enduring impact and hope for our patients and their loved ones. For more information, please visit Together With GSK Oncology Get an inside look at ZEJULA and browse our collection of videos to learn how it may help appropriate…
AstraZeneca
- FLASCO
- March 25, 2015
- No Comments
Company Overview Patient Assistance Programs Overview AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly-growing portfolio of new medicines that has the potential to transform patients’ lives and the Company’s future. With at least six new medicines to be launched between 2014 and 2020, and a broad pipeline of small molecules and biologics…
Johnson & Johnson
- Amanda Bridges
- February 9, 2015
- No Comments
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare…
Boehringer Ingelheim
- Amanda Bridges
- January 13, 2015
- No Comments
Boehringer Ingelheim in Oncology Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim Oncology, we are giving patients new hope, by taking cancer on. We are dedicated to collaborating with the oncology community on a shared journey to deliver leading science. Our primary focus is in lung and gastrointestinal cancers, with the…
Takeda Oncology
- Amanda Bridges
- January 13, 2015
- No Comments
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. Our leadership in oncology extends more than 25 years and includes a range of therapies that have helped to transform the treatment landscape for previously underserved patient populations, in some cases shifting paradigms and becoming standard of care. We…
Genentech
- Amanda Bridges
- January 13, 2015
- No Comments
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit www.gene.com. About Genentech in…
Alexion
- Amanda Bridges
- January 13, 2015
- No Comments
Overview Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing…
